TransMedics Group, Inc. (TMDX)
74.24
+3.10
(+4.36%)
USD |
NASDAQ |
Jun 09, 16:00
74.69
+0.45
(+0.61%)
After-Hours: 17:48
TransMedics Group EPS Diluted (Quarterly) : 0.2021 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.6165 |
| DexCom, Inc. | 0.5109 |
| Integer Holdings Corp. | 0.4794 |
| Globus Medical, Inc. | 0.8995 |
| GlucoTrack, Inc. | -2.646 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 7.315M |
| Revenue (Quarterly) | 173.93M |
| Total Expenses (Quarterly) | 166.62M |
| Enterprise Value | 2.859B |
| Gross Profit Margin (Quarterly) | 57.07% |
| Profit Margin (Quarterly) | 4.21% |
| Earnings Yield | 5.87% |
| Operating Earnings Yield | 3.21% |
| Normalized Earnings Yield | 5.869 |